Cardiology (all articles)
Systematic Review: Change in resting heart rate and risk for all-cause mortality.
1 Feb, 2022 | 08:40h | UTC
Commentary on Twitter
What's the resting heart rate? How does it change? To keep in mind: there may be a correlation w all-cause mortality. Check the #EJPC paper of the week by @WDerman @m_heine01 et al. https://t.co/fCq0NxIx4v#CVPrev #EAPC_ESC #heart @m_piepoli @SilCastelletti @paolo_emilio pic.twitter.com/xJn2nbmPLS
— European Society of Cardiology Journals (@ESC_Journals) January 30, 2022
Review: Primary care-based cardiovascular disease risk management after adverse pregnancy outcomes.
1 Feb, 2022 | 08:29h | UTCPrimary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (if the link is paywalled, try this one)
See also: thread from the author on Twitter summarizing the article
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (recent studies on the subject)
Registry study in Denmark found an increased bleeding risk with the association of systemic Fluconazole and Apixaban (OR 3.5; 95% CI, 1.4-10.6).
1 Feb, 2022 | 08:13h | UTC
Position Paper: Preventing heart failure.
30 Jan, 2022 | 14:53h | UTC
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
30 Jan, 2022 | 14:34h | UTCMyocarditis after BNT162b2 Vaccination in Israeli Adolescents – New England Journal of Medicine
Related:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Commentary on Twitter
Data from the Israeli MOH show estimates of myocarditis risk in the 21 days after a first & second dose of vaccine were 0.56 per 100,000 and 8.09 per 100,000 among male recipients and 0 per 100,000 and 0.69 per 100,000 among females. https://t.co/M6kxVA2toS pic.twitter.com/bQ4TBmcrj4
— NEJM (@NEJM) January 29, 2022
Systematic Review: Low‐carbohydrate vs. balanced‐carbohydrate diets for reducing weight and cardiovascular risk.
30 Jan, 2022 | 14:28h | UTC
Commentary on Twitter
https://twitter.com/CochraneUK/status/1487879806100414474
M-A: SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure.
30 Jan, 2022 | 13:56h | UTC
Commentary on Twitter
SGLT-2 inhibitors improve CV outcomes irrespective of heart failure history and LVEF: a meta-analysis of RCTs https://t.co/QPRCzT9olH#EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava pic.twitter.com/sESFn7Fdxg
— European Society of Cardiology Journals (@ESC_Journals) January 29, 2022
Registry study in South Korea showed delayed hospitalization for Non–ST-Segment Elevation Myocardial Infarction is associated with increased risk of 3-year all-cause mortality.
30 Jan, 2022 | 13:45h | UTCClinical Outcomes in Patients With Delayed Hospitalization for Non–ST-Segment Elevation Myocardial Infarction – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Delays in NSTEMI hospitalization linked to lower survival – MDedge Cardiology
Review: Geriatric syndromes in older adults undergoing cardiovascular interventions.
30 Jan, 2022 | 13:46h | UTC
Commentary on Twitter
The rapidly growing older adult population is frequently affected by a multitude of geriatric- or age-associated conditions that influence cardiovascular outcomes collectively known as, geriatric syndromes. Read more: https://t.co/LFQRwD2rqj #ACCGeriatric #cvGeri @DrDamluji
— American College of Cardiology (@ACCinTouch) January 28, 2022
Cohort Study: Bullous Pemphigoid is associated with a 5-fold higher risk of cardiovascular mortality.
28 Jan, 2022 | 08:11h | UTCRisk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid – JAMA Dermatology (link to abstract – $ for full-text)
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
28 Jan, 2022 | 08:05h | UTC
ESC Position Statement: Cardiovascular effects of doping substances, commonly prescribed medications, and ergogenic aids in relation to sports.
27 Jan, 2022 | 09:43h | UTCNews Release: Athletes warned against potential dangers of natural supplements – European Society of Cardiology
Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.
26 Jan, 2022 | 02:23h | UTCRelated:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
USPSTF Recommendation Statement: Still not enough evidence to recommend atrial fibrillation screening.
26 Jan, 2022 | 02:08h | UTCAuthor Interview: USPSTF Recommendation: Screening for Atrial Fibrillation – JAMA
Editorials:
Screening for Atrial Fibrillation—More Data Still Needed – JAMA
Screening for Atrial Fibrillation—New Devices, Same Challenges – JAMA Internal Medicine
Screening for Atrial Fibrillation—Refining the Target – JAMA Network Open
JAMA Patient Page: Screening for Atrial Fibrillation
Commentary: USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking – TCTMD
Guidelines on the management of Type B aortic dissection.
26 Jan, 2022 | 02:06h | UTCNews Release: New practice guideline addresses diagnosis, treatment of type B aortic dissection – The Society of Thoracic Surgeons
An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.
26 Jan, 2022 | 01:44h | UTCNews release: Using the eye as a window into heart disease – University of Leeds
Original study: Predicting myocardial infarction through retinal scans and minimal personal information – Nature Machine Intelligence (link to abstract – $ for full-text)
Systematic Review: Ultrafiltration for acute heart failure.
26 Jan, 2022 | 01:33h | UTCUltrafiltration for acute heart failure – Cochrane Library
Commentary: Fluid removal therapy in acute heart failure – Cochrane Library
New CPR guidance addresses more contagious COVID-19 variants amidst evolving pandemic.
25 Jan, 2022 | 09:48h | UTCNews release: New CPR guidance addresses more contagious COVID-19 variants amidst evolving pandemic – American Heart Association
A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.
25 Jan, 2022 | 09:43h | UTCNews release: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians
Related:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
25 Jan, 2022 | 09:25h | UTC
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
25 Jan, 2022 | 09:24h | UTC
Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.
25 Jan, 2022 | 09:13h | UTC
Commentary on Twitter
A new study using data from the #GBD 2019 study estimated trends in congenital #heartdisease (CHD) mortality in 204 countries and territories over the past 30 years.
Read more here: https://t.co/6NtW0TYMAG pic.twitter.com/VLCU9OuOwx
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) January 14, 2022
No amount of alcohol is good for the heart, says World Heart Federation.
24 Jan, 2022 | 08:23h | UTCNews Release: No amount of alcohol is good for the heart, says World Heart Federation
Commentary: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN
AHA Statement: Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease.
24 Jan, 2022 | 08:21h | UTCNews Release: Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease – American Heart Association
Review: Health literacy interventions for secondary prevention of coronary artery disease.
24 Jan, 2022 | 08:12h | UTC